126-13-6CC(=O)OC[C@H]1O[C@H](O[C@]2(COC(C)=O)O[C@H](COC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@@H]2OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)CUVGUPMLLGBCFEJ-SWTLDUCYSA-NSucrose acetate isobutyrate is a glycoside.
Cosmetic ingredients (Sucrose Acetate Isobutyrate) -> CIR (Cosmetic Ingredient Review)
Film forming; Plasticiser
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 99.2% (119 of 120) of all reports.
Not Classified
Aggregated GHS information provided per 120 reports by companies from 3 notifications to the ECHA C&L Inventory.
Chemical: .alpha.-D-Glucopyranoside, 6-O-acetyl-1,3,4-tris-O-(2-methyl-1-oxopropyl)-.beta.-D-fructofuranosyl, 6-acetate 2,3,4-tris[2-methylpropanoate]
Regulation (EC) No 1333/2008 (amended)
.alpha.-D-Glucopyranoside, 6-O-acetyl-1,3,4-tris-O-(2-methyl-1-oxopropyl)-.beta.-D-fructofuranosyl, 6-acetate 2,3,4-tris(2-methylpropanoate): Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Causes muscle weakness and diarrhea in intraperitoneal, lethal-dose studies of rats; [RTECS] No affect on liver enzymes in 20 volunteers who ingested 10 mg/kg/day for 14 days; [HSDB] May cause mild eye irritation, based on animal studies; [MSDSonline]
AFTER SINGLE ORAL DOSE OF.../SUCROSE ACETATE (14)C-ISOBUTYRATE/ @ A DOSE LEVEL OF 1 MG/KG, HUMAN SUBJECTS ELIMINATED 40-66% OF (14)CO2 IN EXHALED AIR, 15-21% IN URINE, & 10% IN FECES OVER 30 DAYS, & RATS GAVE SIMILAR PATTERN OF ELIMINATION.
/AFTER ORAL ADMIN OF SUCROSE ACETATE (14)C-ISOBUTYRATE/ PARTIALLY ESTERIFIED SUCROSE DERIVATIVES, AS WELL AS TRACES OF SUCROSE PER SE, WERE PRESENT IN URINE; THESE METABOLITES WERE SIMILAR IN MEN & IN RATS BUT SOMEWHAT DIFFERENT IN DOGS.
...SUCROSE ACETATE ISOBUTYRATE IS METABOLIZED SIMILARLY IN RATS & IN MAN, BUT THAT THE DOG PROCESSES THIS SUGAR DERIVATIVE RATHER DIFFERENTLY BOTH WITH REGARD TO DISPOSITION OF THE DOSE & TO THE NATURE OF URINARY EXCRETORY PRODUCTS.
Dogs and rats received a single dose of (14)C-sucrose acetate isobutyrate ... The rats eliminated 7-10% of the dose in the urine in 30-46 hr and the dogs, 2.8-5.2% of the dose in the urine in 29-30 hr. Size exclusion chromatography of the dog and rat urine showed that (14)C-labelled molecules larger than sucrose were not present to any significant extent. The nature of the metabolites was not determined, although sucrose, glucose and fructose appeared to be absent.
A male /human/ subject was given a single dose of (14)C-sucrose acetate isobutyrate at a dose level of 1.18 mg/kg bw. Samples of urine were collected before dosing and at 0 and 6.2 hr after dosing, and subjected to various chromatographic procedures. Glucose, fructose and the esters of fructose and sucrose were not present in the urine. Two unidentified peaks were considered to be the principal metabolites of sucrose acetate isobutyrate ... .
AFTER SINGLE ORAL DOSE OF.../SUCROSE ACETATE (14)C-ISOBUTYRATE/ @ A DOSE-LEVEL OF 1 MG/KG, HUMAN SUBJECTS ELIMINATED 40-66% OF (14)CO2 IN EXHALED AIR, 15-21% IN URINE, & 10% IN FECES OVER 30 DAYS, & RATS GAVE SIMILAR PATTERN OF ELIMINATION, BUT (2) DOGS FED 3 & 5 MG/KG ELIMINATED 53 & 46% IN FECES WITHIN 7 DAYS.
IN RATS, ORALLY ADMIN (14)C SUCROSE ACETATE ISOBUTYRATE WAS HYDROLYZED IN THE GI TRACT PRIOR TO ABSORPTION, & THE SUBSEQUENT FATE OF ADMIN RADIOACTIVITY WAS ANALOGOUS TO THAT OF (14)C SUCROSE. HUMAN STUDIES SHOWED THAT, FOLLOWING A SINGLE ORAL DOSE OR 7 DAILY DOSES OF 1 G SUCROSE ACETATE ISOBUTYRATE (SAIB), THE URINE CONTAINED NO SUCROSE OR PARTIALLY HYDROLYZED SUCROSE ACETATE ISOBUTYRATE. MICROFLORA ASSOCIATED WITH THE LARGE BOWEL EXHIBITED A LIMITED CAPACITY TO HYDROLYZED SUCROSE ACETATE ISOBUTYRATE.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
126-13-6CHEBI:177717clear colorless to slightly yellow viscous liquid
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Twenty subjects (10 males and 10 females) between 18 and 22 years of age ingested a daily dose of sucrose acetate isobutyrate at a level equivalent to 10 mg/kg bw/day for a period of 14 days. The dose was taken as a bolus each morning. The following blood parameters were measured prior to treatment and at days 7 and 18 of the study: aspartate aminotransferase, alanine aminotransferase, serum alkaline phosphatase, serum bilirubin, total protein, albumin, uric acid, blood area nitrogen, erythrocyte sedimentation rate, sodium, potassium, phosphorous, total CO2, cholesterol and glucose. There were no significant differences in any parameters in any individual ... .
In another 14-day study, 12 male and 12 female subjects were divided evenly by sex into 3 groups, receiving a carbonated drink only (controls), or a single daily dose of 7.0 or 20.0 mg sucrose acetate isobutyrate/kg bw/day in a carbonated drink. In addition, four men received 20 mg sucrose acetate isobutyrate/kg bw/day for 1 or 3 days only in a pilot experiment to provide early evaluation of possible alterations in normal hepatic function. The subjects were 21 to 42 years of age. Blood was collected prior to testing and on days 7 and 14 for hematological (platelets, total and differential white blood cells count, erythrocyte sedimentation rate, Hct and hemoglobin) and clinical chemistry (total protein, albumin, A/G ratio, calcium, cholesterol, glucose, blood area nitrogen, uric acid total bilirubin, serum alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase) parameters. Standard urinalysis parameters were also recorded at these times. A 45 minute bromosulfophthalein retention test (5 mg/kg bw bromosulfophthalein was also conducte on all subjects prior to treatment and after completion of treatment. Treatment with sucrose acetate isobutyrate did not affect any of these parameters for any individual ... .
Twenty-seven adult subjects, 13 men and 14 women, between the ages of 18 to 55, received sucrose acetate isobutyrate in an aqueous/orange juice emulsion daily for 14 days at a dose of 20 mg/kg bw. In the 7 days prior to treatment, each subject acted as his/her own control by ingesting an orange juice beverage and placebo emulsion. Blood samples were collected from each subject on days -6, 0, 7 and 14 of treatment for measurement of routine hematological and clinical chemistry parameters, including specific indicators of hepatobiliary function (serum alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, gamma-glutamyl transferase, total bilirubin, direct bilirubin, bile acids and serum proteins). No treatment-related changes were detected in any of these parameters over the 14-day dosing period ... .
...95-DAY SUB-ACUTE TOXICITY TESTING OF DOGS & RATS WITH SUCROSE ACETATE ISOBUTYRATE SHOWED IT TO BE WITHOUT EFFECT.
Five groups of B6C3F1/Cr1BR mice (10/sex/group) received approx 0, 0.625, 1.25, 2.5 or 5.0 g sucrose acetate isobutyrate/kg bw/day in the diet for 4 wk. Body weights, food consumption and physical exam were recorded at initiation of treatment and weekly during the study. Feeding of sucrose acetate isobutyrate at these doses for 4 wk had no effect on the biological performance of the treated animals. No treatment-related observations were noted at the terminal necropsy ... .
A three-week feeding study was conducted in which groups of 30 Sprague-Dawley rats (15/sex/group) were fed 0, 5,000 or 50,000 ppm sucrose acetate isobutyrate in the diet. Five rats/sex/group were sacrificed after 1, 2 and 3 weeks of treatment. Twice weekly determinations of body weight and food consumption indicated no adverse effect of treatment on these parameters. Daily examination of the rats during the first week revealed a high incidence of respiratory disease which was not related to treatment; no animals died. Gross necropsy at sacrifice did not reveal any treatment-related changes. Absolute and relative liver weights were comparable between control and treated groups ... .
In a series of studies, Sprague-Dawley rats were divided into 14 treatment groups of 10 animals/sex/group and fed diets containing sucrose acetate isobutyrate at dietary levels of 1.0, 2.0 and 4.0% (w/w) supplemented with 5% corn oil (w/w). The groups were fed the test diets for 28 or 56 days continuously or for 28 days followed or preceded by 28 days on control diet. Two groups were fed the control diet containing corn oil only for 28 or 56 days continuously. At the termination of the study, animals were sacrificed and blood collected for determination of serum alkaline phosphatase (SAP), ornithine carbamyl transferase (OCT), blood urea nitrogen (BUN), triglyceride, cholesterol and glucose. The animals were autopsied, examined grossly, and absolute and relative liver weights were determined. Liver microsomal enzyme activity (p-nitroanisole demethylase), glucose-6-phosphatase and bilirubin-beta-D-glucuronyl transferase were determined and the liver was histologically examined. Weight gain and feed consumption of test and control groups were similar. There were no significant changes in the serum chemistry of the test animals. Gross pathology at autopsy was negative and liver weights (absolute and relative) were similar for test and control groups. Microsomal enzyme activity was similar for test and control animals, with the exception that glucose-6-phosphatase activity was reduced in male rats on the 4% sucrose acetate isobutyrate diet ... .
For more Non-Human Toxicity Excerpts (Complete) data for SUCROSE ACETATE ISOBUTYRATE (33 total), please visit the HSDB record page.
Male albino Holtzman rats, about 250 g, were intubated with (14)C-sucrose acetate isobutyrate of specific activity 0.411 uCi/mg ... in corn oil at dose levels equivalent to 27 or 100 mg/kg bw. The proportion of the admin dose absorbed from the GI tract was greater at the low dose (74-82%) than at the high dose (45-50%). Elimination of 88-90% of the admin dose occurred in 48 hr. The relative proportion of radioactivity eliminated by the various routes varied with the dose. At the high dose level, 54-56% of the absorbed activity was eliminated as CO2 and 26-28% in the urine. At the lower dose, 63-67% of the absorbed activity was eliminated in CO2 and 23-25% in the urine. Four days after the admin of the test cmpd, less than 1% of the admin radioactivity was retained in the GI tract, blood, liver and kidney. Chromatography of extracts of the 24-hr feces of rats showed the presence of sucrose acetate isobutyrate and other metabolites. Most of the radioactivity in urine was in the form of sucrose, although other unidentified substances were also present ... .
... Male albino Holtzman rats weighing approx 250 g received 100 mg/kg bw of (14)C-sucrose acetate isobutyrate (specific activity, 0.38 uCi/mg) in corn oil by gavage. At termination of the study, 3 or 3.5 hr after dosing, 78-84% of the radioactivity was recovered from the GI contents. An additional 7-9% of the radioactivity was recovered from the stomach, intestinal and cecal tissues. Less than 4% of the radioactivity was excreted in the breath, urine and feces within 3-3.5 hr after dosing, indicating that little absorption had taken place. Extracts of the GI contents and organs were found to contain sucrose and partially acylated sucrose esters in addition to unchanged SAIB ... .
For more Absorption, Distribution and Excretion (Complete) data for SUCROSE ACETATE ISOBUTYRATE (15 total), please visit the HSDB record page.
CIR ingredient: Sucrose Acetate Isobutyrate
Used as a modifier for lacquers, in hot-melt coating formulations, as a plasticizer (extrudable plastics), to adjust specific gravities of flavors for carbonated beverages (not approved in the US), and in citrus-flavored beverages as a substitute for brominated vegetable oils (in Canada); [HSDB] Used in cosmetics; [MSDSonline]
Painting (Pigments, Binders, and Biocides) [Category: Paint]
USED IN CITRUS-FLAVORED BEVERAGES IN CANADA AS A SUBSTITUTE FOR BROMINATED VEGETABLE OILS AND IS PERMITTED AT LEVELS AS HIGH AS 50 PPM.
MODIFIER FOR LACQUERS, HOT-MELT COATING FORMULATIONS, EXTRUDABLE PLASTICS
Used for adjusting specific gravities of flavor oil mixtures for carbonated beverages, but not approved in the United States.
CLEAR SUCROSE DERIVATIVE AVAILABLE EITHER AS SEMI-SOLID (100%), OR AS A 90% SOLN IN ETHYL ALC.
A NAIL POLISH COMPRISES A MIXT OF SUCROSE BENZOATE, SUCROSE ACETATE ISOBUTYRATE, & IF DESIRED, A PLASTICIZER (ORG PHTHALATE, ADIPATE, OR PHOSPHATE) WHICH REPLACES THE TOLUENESULFONAMIDE-FORMALDEHYDE RESIN GENERALLY USED FOR ADHESION OF THE POLISH TO FINGER- OR TOENAIL.
Food Additives -> ADJUVANT; CLOUDING_AGENT; EMULSIFYING_SALT -> JECFA Functional Classes
Cosmetics -> Film forming; Plasticiser
용도food additive, plasticizer